SCHEMBL20101038

SCHEMBL20101038

FC(F)(F)c1ccc2sc(N/N=C(\c3ccccc3)c3ccccn3)nc2c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 2/20 0.71
ALDH1A1 P00352 2/20 0.71
CYP1A2 P05177 1/20 0.71
CYP3A4 P08684 1/20 0.71
HIF1A Q16665 1/20 0.71
MEN1 O00255 1/20 0.47
GAA P10253 1/20 0.47
HPGD P15428 1/20 0.47
ALOX12 P18054 1/20 0.47
KMT2A Q03164 1/20 0.47
DYRK1A Q13627 1/20 0.47
AGTR1 P30556 2/20 0.45
NCS1 P62166 1/20 0.43
KDM4E B2RXH2 2/20 0.43
KDM6B O15054 1/20 0.43
TET3 O43151 1/20 0.43
KDM4A O75164 1/20 0.43
KDM4B O94953 1/20 0.43
KDM5A P29375 1/20 0.43
KDM5C P41229 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20101035 0.85 HSP90AA1 (0.54) HSP90AA1ALDH1A1CYP1A2CYP3A4HIF1A
SCHEMBL20101036 0.84 HSP90AA1 (0.76) HSP90AA1ALDH1A1CYP1A2CYP3A4HIF1A
SCHEMBL15427107 0.84 HSP90AA1 (1.00) HSP90AA1ALDH1A1CYP1A2CYP3A4HIF1A
SCHEMBL20101027 0.83 DYRK1A (0.48) HSP90AA1ALDH1A1CYP1A2CYP3A4HIF1A
SCHEMBL20101082 0.76 HSP90AA1 (0.85) HSP90AA1ALDH1A1CYP1A2CYP3A4HIF1A
SCHEMBL20101023 0.76 MEN1 (0.55) HSP90AA1ALDH1A1CYP1A2CYP3A4HIF1A
SCHEMBL17963013 0.71 HSP90AA1 (0.57) HSP90AA1ALDH1A1CYP1A2CYP3A4HIF1A
SCHEMBL31151098 0.70 ALDH1A1 (0.56) HSP90AA1ALDH1A1CYP1A2CYP3A4HIF1A
SCHEMBL31151100 0.70 ALDH1A1 (0.56) HSP90AA1ALDH1A1CYP1A2CYP3A4HIF1A
SCHEMBL28366328 0.70 MAOA (0.72) HSP90AA1ALDH1A1CYP1A2CYP3A4HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018081612-A1 COMPOUNDS AND METHODS FOR TREATING CANCER ACTAVALON, INC. (US) 2018-05-03 WO disclosed